Because previous reports have suggested that recombinant adiponectin was able to inhibit the proliferation of cultured breast cancer cell lines (MDA-MB-231 and MCF-7) [11], [12], we investigated whether recombinant adiponectin can also suppress B16F10 cell proliferation in vitro. Here, ADIPOQ is linked to breast carcinoma.